Lohou, E.; Sasaki, N.A.; Boullier, A.; Duplantier, M.; Sonnet, P.
Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer’s Disease. Pharmaceuticals 2019, 12, 162.
https://doi.org/10.3390/ph12040162
AMA Style
Lohou E, Sasaki NA, Boullier A, Duplantier M, Sonnet P.
Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer’s Disease. Pharmaceuticals. 2019; 12(4):162.
https://doi.org/10.3390/ph12040162
Chicago/Turabian Style
Lohou, Elodie, N. André Sasaki, Agnès Boullier, Marine Duplantier, and Pascal Sonnet.
2019. "Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer’s Disease" Pharmaceuticals 12, no. 4: 162.
https://doi.org/10.3390/ph12040162
APA Style
Lohou, E., Sasaki, N. A., Boullier, A., Duplantier, M., & Sonnet, P.
(2019). Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer’s Disease. Pharmaceuticals, 12(4), 162.
https://doi.org/10.3390/ph12040162